{"id":"https://openalex.org/W2503538439","doi":"https://doi.org/10.1158/1538-7445.am2016-3041","title":"Abstract 3041: Blood-brain barrier penetrating ATM inhibitor (AZ32) radiosensitises intracranial gliomas in mice","display_name":"Abstract 3041: Blood-brain barrier penetrating ATM inhibitor (AZ32) radiosensitises intracranial gliomas in mice","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2503538439","doi":"https://doi.org/10.1158/1538-7445.am2016-3041","mag":"2503538439"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-3041","doi":"https://doi.org/10.1158/1538-7445.am2016-3041","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-3041","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091761486","display_name":"Steve T. Durant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steve T. Durant","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077569930","display_name":"Jeremy D. Karlin","orcid":"https://orcid.org/0000-0003-4322-1041","observed_orcids":["https://orcid.org/0000-0003-4322-1041"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy Karlin","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077948241","display_name":"Kurt G. Pike","orcid":"https://orcid.org/0000-0002-9731-7500","observed_orcids":["https://orcid.org/0000-0002-9731-7500"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kurt Pike","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042144456","display_name":"Nicola Colclough","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Colclough","raw_affiliation_strings":["3AstraZeneca, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AstraZeneca, Manchester, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076202183","display_name":"Nitai D. Mukhopadhyay","orcid":"https://orcid.org/0000-0002-1530-9516","observed_orcids":["https://orcid.org/0000-0002-1530-9516"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Mukhopadhyay","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S F. Ahmad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S F. Ahmad","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066345126","display_name":"Jason M. Beckta","orcid":"https://orcid.org/0000-0003-0756-6173","observed_orcids":["https://orcid.org/0000-0003-0756-6173"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J M. Bekta","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019761079","display_name":"Mary E. Tokarz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Tokarz","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049197685","display_name":"Catherine Bardelle","orcid":"https://orcid.org/0009-0007-7090-3861","observed_orcids":["https://orcid.org/0009-0007-7090-3861"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catherine Bardelle","raw_affiliation_strings":["3AstraZeneca, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AstraZeneca, Manchester, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108722623","display_name":"Gareth Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth Hughes","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bhavika Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bhavika Patel","raw_affiliation_strings":["3AstraZeneca, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AstraZeneca, Manchester, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031414676","display_name":"Andrew G. Thomason","orcid":"https://orcid.org/0000-0001-5427-841X","observed_orcids":["https://orcid.org/0000-0001-5427-841X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Thomason","raw_affiliation_strings":["3AstraZeneca, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AstraZeneca, Manchester, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037908617","display_name":"Elaine B. Cadogan","orcid":"https://orcid.org/0000-0002-9757-8305","observed_orcids":["https://orcid.org/0000-0002-9757-8305"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elaine Cadogan","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022667082","display_name":"Ian P. Barrett","orcid":"https://orcid.org/0009-0005-7164-0376","observed_orcids":["https://orcid.org/0009-0005-7164-0376"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian Barrett","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055277039","display_name":"Alan Lau","orcid":"https://orcid.org/0000-0003-1055-9812","observed_orcids":["https://orcid.org/0000-0003-1055-9812"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Lau","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051322178","display_name":"Martin Pass","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Pass","raw_affiliation_strings":["1AstraZeneca, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047550067","display_name":"Kristoffer C. Valerie","orcid":"https://orcid.org/0000-0002-7907-7873","observed_orcids":["https://orcid.org/0000-0002-7907-7873"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristoffer Valerie","raw_affiliation_strings":["2Virginia Commonwealth University, Richmond, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Virginia Commonwealth University, Richmond, VA;","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"3041","last_page":"3041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atm-kinase-inhibitor","display_name":"ATM kinase inhibitor","score":0.7870000004768372},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.8360000252723694},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8399999737739563},{"id":"https://openalex.org/keywords/intracranial-glioma","display_name":"intracranial glioma","score":0.7160000205039978},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7229999899864197},{"id":"https://openalex.org/keywords/whole-brain-radiotherapy","display_name":"whole brain radiotherapy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/orthotopic-glioma-model","display_name":"orthotopic glioma model","score":0.6539999842643738},{"id":"https://openalex.org/keywords/brain-pharmacokinetics","display_name":"brain pharmacokinetics","score":0.5960000157356262},{"id":"https://openalex.org/keywords/radioresistance-biology","display_name":"radioresistance (biology)","score":0.5709999799728394},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.7269999980926514},{"id":"https://openalex.org/keywords/redox-stress","display_name":"redox stress","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C58962609","wikidata":"https://www.wikidata.org/wiki/Q2353022","display_name":"Radioresistance","level":3,"score":0.7519376873970032},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6871724128723145},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6494802832603455},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5623445510864258},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5335457921028137},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.49196264147758484},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4536260664463043},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45040708780288696},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.43047115206718445},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4248838424682617},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.35676220059394836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32256975769996643},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.15925034880638123},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12861165404319763},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07351091504096985}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-3041","doi":"https://doi.org/10.1158/1538-7445.am2016-3041","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-3041","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6600000262260437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2235074116","https://openalex.org/W2123602693","https://openalex.org/W2766459017","https://openalex.org/W2022503084","https://openalex.org/W2282707216","https://openalex.org/W2901926015","https://openalex.org/W2019927904","https://openalex.org/W2963466627","https://openalex.org/W2116193195","https://openalex.org/W2081927132"],"abstract_inverted_index":{"Abstract":[0],"Ataxia-telangiectasia":[1],"mutated":[2],"(ATM)":[3],"kinase":[4],"is":[5,65,151,156,160,201,221],"a":[6,172,312,327],"central":[7],"DNA":[8,17,23,181],"damage":[9,182],"response":[10],"(DDR)":[11],"component":[12],"signalling":[13,180],"the":[14,46,233,247,319,402,407],"presence":[15],"of":[16,31,60,275,287,321,401,406],"double":[18],"strand":[19,42],"breaks":[20,43],"(DSBs)":[21],"to":[22,51,67,70,87,137,189,206,216],"repair,":[24],"checkpoint":[25,125],"and":[26,44,78,104,209,218,249,332],"survival":[27,58,286],"pathways.":[28],"Clinical":[29],"doses":[30,274],"fractionated":[32,341],"radiotherapy":[33,342],"directed":[34],"at":[35],"tumours":[36,336],"kill":[37],"cells":[38,53,114,253],"by":[39,118,141,304],"inducing":[40],"single":[41],"DSBs,":[45],"latter":[47],"being":[48],"particularly":[49,139],"lethal":[50],"all":[52,72],"if":[54],"not":[55],"repaired.":[56],"Poor":[57],"rates":[59],"glioblastoma":[61,131],"multiforme":[62,132],"(GBM)":[63,133],"patients":[64],"attributed":[66],"an":[68,79,202],"inability":[69],"excise":[71],"invasive":[73],"tumor":[74,305],"tissue":[75],"(if":[76],"operable)":[77],"intrinsic":[80],"tumour":[81,193],"chemo/radioresistance,":[82],"which":[83],"has":[84,186],"been":[85,187],"linked":[86,188],"elevated":[88],"ATM":[89,95,154,159,200,268,390],"activity":[90,155],"in":[91,102,105,164,167,179,192,254,280,283,338,344,396],"glioma":[92,112,291],"stem":[93,113],"cells.":[94],"inhibition":[96],"(ATMi)":[97],"radiosensitises":[98,110,393],"cancer":[99],"cell":[100,123,134],"lines":[101,135],"vitro":[103],"vivo.":[106],"ATMi":[107,166,243,325],"also":[108],"acutely":[109],"patient-derived":[111],"more":[115],"effectively":[116],"than":[117],"inhibiting":[119],"other":[120,334],"DDR":[121,248],"or":[122],"cycle":[124],"components":[126],"(PARP,":[127],"ATR,":[128],"Chk1).":[129],"Checkpoint-defective":[130],"seem":[136],"be":[138],"radio-sensitised":[140],"ATMi.":[142],"In":[143],"addition,":[144],"several":[145],"studies":[146,198,220],"suggest":[147,199],"that":[148,222],"normal":[149],"brain":[150,168,263,277],"radioprotected":[152],"when":[153],"deficient,":[157],"suggesting":[158],"required":[161],"for":[162,330,410],"apoptosis":[163],"neurons.":[165],"may":[169],"therefore":[170],"provide":[171],"wide":[173],"therapeutic":[174],"margin.":[175],"Furthermore,":[176],"ATM's":[177],"role":[178],"independent":[183],"redox":[184],"stress":[185],"promoting":[190],"neoangiogenesis":[191],"vasculature.":[194],"Taken":[195],"together,":[196],"these":[197],"extremely":[203],"attractive":[204],"target":[205],"inhibit":[207],"during":[208,270],"potentially":[210,333],"following":[211],"radiotherapy.":[212],"However,":[213],"one":[214],"impediment":[215],"preclinical":[217],"clinical":[219,322,346],"current":[223],"ATMi's":[224],"have":[225],"limited":[226],"CNS":[227],"bioavailability.":[228],"We":[229],"report":[230],"AZ32":[231,245],"as":[232,326],"first":[234],"known":[235],"selective,":[236],"orally":[237],"bioavailable":[238],"blood-brain":[239],"barrier":[240,388],"(BBB)":[241],"penetrating":[242,389],"probe.":[244],"inhibits":[246],"radiosensitizes":[250],"p53/checkpoint-defective":[251],"GBM":[252,331],"vitro.":[255],"Oral":[256],"daily":[257,273],"dosing":[258],"providing":[259],"sufficient":[260],"mouse":[261,290],"free":[262],"pharmacokinetic":[264],"exposures":[265],"over":[266],"AZ32's":[267],"IC50,":[269],"just":[271],"four":[272],"whole":[276],"irradiation":[278],"results":[279],"significant":[281],"improvement":[282],"median":[284],"overall":[285],"syngeneic":[288],"orthotopic":[289,314],"models":[292],"(log-rank":[293],"AZ32/radiation":[294],"vs.":[295],"radiation":[296],"p":[297],"=":[298],"0.0194).":[299],"Tumor":[300],"eradication":[301],"was":[302,309],"confirmed":[303],"imaging.":[306],"This":[307],"result":[308],"recapitulated":[310],"with":[311,340],"human":[313],"model.":[315],"These":[316],"findings":[317],"support":[318],"development":[320],"grade":[323],"BBB-penetrating":[324],"potential":[328],"treatment":[329],"intracranial":[335,394],"dosed":[337],"combination":[339],"used":[343],"standard":[345],"practice.":[347],"Citation":[348],"Format:":[349],"Steve":[350],"T.":[351],"Durant,":[352],"Jeremy":[353],"Karlin,":[354],"Kurt":[355],"Pike,":[356],"Nicola":[357],"Colclough,":[358],"N":[359],"Mukhopadhyay,":[360],"S":[361],"F.":[362],"Ahmad,":[363],"J":[364],"M.":[365],"Bekta,":[366],"M":[367],"Tokarz,":[368],"Catherine":[369],"Bardelle,":[370],"Gareth":[371],"Hughes,":[372],"Bhavika":[373],"Patel,":[374],"Andrew":[375],"Thomason,":[376],"Elaine":[377],"Cadogan,":[378],"Ian":[379],"Barrett,":[380],"Alan":[381],"Lau,":[382],"Martin":[383],"Pass,":[384],"Kristoffer":[385],"Valerie.":[386],"Blood-brain":[387],"inhibitor":[391],"(AZ32)":[392],"gliomas":[395],"mice.":[397],"[abstract].":[398],"In:":[399],"Proceedings":[400],"107th":[403],"Annual":[404],"Meeting":[405],"American":[408],"Association":[409],"Cancer":[411,422],"Research;":[412],"2016":[413],"Apr":[414],"16-20;":[415],"New":[416],"Orleans,":[417],"LA.":[418],"Philadelphia":[419],"(PA):":[420],"AACR;":[421],"Res":[423],"2016;76(14":[424],"Suppl):Abstract":[425],"nr":[426],"3041.":[427]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}